X4 Pharmaceuticals, Inc. buy Cantor Fitzgerald
Start price
31.05.24
/
50%
€0.93
Target price
31.05.25
€4.61
Performance (%)
-43.07%
Price
10:19
€0.53
Summary
This prediction is currently active. Massive losses of -43.07% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 31.05.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| X4 Pharmaceuticals, Inc. | -13.019% | -13.019% |
| iShares Core DAX® | 1.133% | -0.156% |
| iShares Nasdaq 100 | 0.815% | 8.801% |
| iShares Nikkei 225® | 1.990% | 3.286% |
| iShares S&P 500 | -0.014% | 5.438% |
Comments by Cantor_Fitzgerald for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat